Titan Medical Inc. (TMDI): Price and Financial Metrics

Titan Medical Inc. (TMDI): $0.50

0.02 (+4.17%)

POWR Rating

Component Grades














  • Growth is the dimension where TMDI ranks best; there it ranks ahead of 55.29% of US stocks.
  • The strongest trend for TMDI is in Growth, which has been heading up over the past 127 days.
  • TMDI ranks lowest in Stability; there it ranks in the 13th percentile.

TMDI Stock Summary

  • With a year-over-year growth in debt of -52.64%, Titan Medical Inc's debt growth rate surpasses only 6.78% of about US stocks.
  • The volatility of Titan Medical Inc's share price is greater than that of 95.28% US stocks with at least 200 days of trading history.
  • Titan Medical Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -75.58%, greater than the shareholder yield of only 5.48% of stocks in our set.
  • Stocks that are quantitatively similar to TMDI, based on their financial statements, market capitalization, and price volatility, are CTMX, LPTX, STTK, SQZ, and SGTX.
  • TMDI's SEC filings can be seen here. And to visit Titan Medical Inc's official web site, go to www.titanmedicalinc.com.

TMDI Valuation Summary

  • TMDI's price/earnings ratio is -5.5; this is 115.07% lower than that of the median Healthcare stock.
  • TMDI's price/sales ratio has moved NA NA over the prior 39 months.
  • TMDI's price/sales ratio has moved NA NA over the prior 39 months.

Below are key valuation metrics over time for TMDI.

Stock Date P/S P/B P/E EV/EBIT
TMDI 2021-08-31 6.7 -9.6 -5.5 -4.8
TMDI 2021-08-30 6.4 -9.3 -5.3 -4.6
TMDI 2021-08-27 6.4 -9.3 -5.3 -4.6
TMDI 2021-08-26 6.4 -9.2 -5.3 -4.5
TMDI 2021-08-25 6.7 -9.6 -5.5 -4.8
TMDI 2021-08-24 6.7 -9.6 -5.5 -4.8

TMDI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TMDI has a Quality Grade of D, ranking ahead of 19.13% of graded US stocks.
  • TMDI's asset turnover comes in at 1.204 -- ranking 14th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows TMDI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 1.204 1 0.875
2019-12-31 0.000 NA 2.640
2019-12-31 0.000 NA 2.640

TMDI Price Target

For more insight on analysts targets of TMDI, see our TMDI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.00 Average Broker Recommendation 1.25 (Strong Buy)

TMDI Stock Price Chart Interactive Chart >

Price chart for TMDI

TMDI Price/Volume Stats

Current price $0.50 52-week high $2.15
Prev. close $0.48 52-week low $0.38
Day low $0.45 Volume 192,800
Day high $0.51 Avg. volume 278,141
50-day MA $0.50 Dividend yield N/A
200-day MA $0.91 Market Cap 55.60M

Titan Medical Inc. (TMDI) Company Bio

Titan Medical Inc. is developing a 3-armed robotic surgical system to permit surgeons to remotely manipulate surgical instruments.

TMDI Latest News Stream

Event/Time News Detail
Loading, please wait...

TMDI Latest Social Stream

Loading social stream, please wait...

View Full TMDI Social Stream

Latest TMDI News From Around the Web

Below are the latest news stories about Titan Medical Inc that investors may wish to consider to help them evaluate TMDI as an investment opportunity.

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Analysts Estimate Titan Medical Inc. (TMDI) to Report a Decline in Earnings: What to Look Out for

Titan Medical Inc. (TMDI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 21, 2022

Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing Strategy

TORONTO, February 07, 2022--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that it has surpassed 200 patents and patent applications. This important milestone demonstrates the company’s commitment to being an innovation leader in single access robotic-assisted surgery. This broad portfolio protects the company’s proprietary

Yahoo | February 7, 2022

Mesa Labs (MLAB) Q3 Earnings Miss Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -19.05% and 13.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 3, 2022

Avion Wealth Buys Vanguard Ultra-Short Bond ETF, Vanguard Short-Term Bond ETF, Boeing Co, Sells ...

Investment company Avion Wealth (Current Portfolio) buys Vanguard Ultra-Short Bond ETF, Vanguard Short-Term Bond ETF, Boeing Co, Vanguard Total Bond Market ETF, Thermo Fisher Scientific Inc, sells Invesco Optimum Yield Diversified Commodity, Bank of New York Mellon Corp, Vanguard Short-Term Government Bond ETF, AT&T Inc, Ovintiv Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Avion Wealth.

Yahoo | January 26, 2022

Read More 'TMDI' Stories Here

TMDI Price Returns

1-mo 13.79%
3-mo -16.39%
6-mo -28.37%
1-year -73.96%
3-year -80.77%
5-year -93.59%
YTD -20.01%
2021 -63.44%
2020 245.45%
2019 -59.43%
2018 -86.44%
2017 25.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8611 seconds.